- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: BI 695502
Total 1224 results
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI)Completed
-
National Cancer Institute (NCI)RecruitingWaldenstrom Macroglobulinemia | Lymphoplasmacytic LymphomaUnited States
-
National Cancer Institute (NCI)Eastern Cooperative Oncology Group; NCIC Clinical Trials Group; SWOG Cancer Research...CompletedStage I Chronic Lymphocytic Leukemia | Stage II Chronic Lymphocytic Leukemia | Stage III Chronic Lymphocytic Leukemia | Stage IV Chronic Lymphocytic LeukemiaUnited States, Canada
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)WithdrawnMantle Cell Lymphoma | CCND1 Positive | CD20-Positive Neoplastic Cells Present
-
Boehringer IngelheimTerminated
-
Hadassah Medical OrganizationCompletedResorbed Alveolar Ridge Prior to Dental Implant InsertionIsrael
-
Boehringer IngelheimEli Lilly and CompanyCompletedDiabetes Mellitus, Type 2Japan
-
Ohio State UniversityCompletedHepatitis C | HCV | Kidney TransplantUnited States
-
BioInvent International ABTerminatedA Phase I/II Study of BI-505 in Conjunction With Autologous Stem Cell Transplant in Multiple MyelomaMultiple MyelomaUnited States
-
National Cancer Institute (NCI)Active, not recruitingRecurrent Small Lymphocytic Lymphoma | Refractory Chronic Lymphocytic Leukemia | Recurrent Chronic Lymphocytic Leukemia | Refractory Small Lymphocytic LymphomaUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)CompletedFollicular Lymphoma | Mantle Cell Lymphoma | Marginal Zone Lymphoma | Chronic Lymphocytic Leukemia | Recurrent Diffuse Large B-Cell Lymphoma | CD20 Positive | T-Cell Non-Hodgkin LymphomaUnited States
-
National Cancer Institute (NCI)NRG OncologyCompletedRecurrent Fallopian Tube Carcinoma | Recurrent Ovarian Carcinoma | Recurrent Primary Peritoneal CarcinomaUnited States
-
National Cancer Institute (NCI)Fox Chase Cancer CenterCompletedStage IV Skin Melanoma | Recurrent Melanoma | Stage IIIB Skin Melanoma | Stage IIIC Skin MelanomaUnited States
-
Cairo UniversityRecruitingSystemic Lupus ErythematosusEgypt
-
Boehringer IngelheimRecruitingSmall Cell Lung Carcinoma (SCLC)Spain, Belgium, Japan, France, Poland, Germany
-
Boehringer IngelheimCompleted
-
University of Wisconsin, MadisonNational Institutes of Health (NIH); National Institute on Aging (NIA)CompletedClostridium DifficileUnited States
-
Boehringer IngelheimCompleted
-
Boehringer IngelheimCompleted
-
Gradalis, Inc.CompletedStage IV Ovarian Cancer | Stage III Ovarian CancerUnited States
-
National Cancer Institute (NCI)CompletedUnspecified Adult Solid Tumor, Protocol Specific | Recurrent Small Cell Lung CancerUnited States
-
Boehringer IngelheimCompleted
-
Lumara Health, Inc.Completed
-
Boehringer IngelheimNot yet recruiting
-
AbbVieBoehringer IngelheimCompleted
-
Boehringer IngelheimCompleted
-
City of Hope Medical CenterNational Cancer Institute (NCI)Active, not recruitingRecurrent Diffuse Large B-Cell Lymphoma | Refractory Diffuse Large B-Cell Lymphoma | Recurrent Transformed B-Cell Non-Hodgkin Lymphoma | Refractory Transformed B-Cell Non-Hodgkin Lymphoma | Recurrent Primary Mediastinal (Thymic) Large B-Cell Cell Lymphoma | Refractory Primary Mediastinal (Thymic)... and other conditionsUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)CompletedClassic Hodgkin Lymphoma | Lugano Classification Stage III Hodgkin Lymphoma AJCC v8 | Lugano Classification Stage IV Hodgkin Lymphoma AJCC v8United States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)RecruitingLymphoma | Acute Lymphoblastic Leukemia | B Acute Lymphoblastic Leukemia | Lymphocytic NeoplasmUnited States
-
ECOG-ACRIN Cancer Research GroupNational Cancer Institute (NCI)Active, not recruitingMantle Cell Lymphoma | Liver LymphomaUnited States
-
University of California, San FranciscoMerck Sharp & Dohme LLCCompletedStage IV Colorectal Cancer AJCC v7 | Stage IVA Colorectal Cancer AJCC v7 | Stage IVB Colorectal Cancer AJCC v7 | Microsatellite Stable | Stage III Colorectal Cancer AJCC v7 | Stage IIIB Colorectal Cancer AJCC v7 | Stage IIIC Colorectal Cancer AJCC v7 | Mismatch Repair Protein ProficientUnited States
-
National Cancer Institute (NCI)CompletedUterine Carcinosarcoma | Recurrent Fallopian Tube Carcinoma | Recurrent Ovarian Carcinoma | Recurrent Primary Peritoneal Carcinoma | Recurrent Uterine Corpus Carcinoma | Ovarian Endometrioid Adenocarcinoma | Ovarian Seromucinous Carcinoma | Endometrial Serous Adenocarcinoma | Lung Carcinoid Tumor | Metastatic... and other conditionsUnited States, Canada
-
Lviv National Medical UniversityRecruitingNutrition Disorders | Chronic Pain | Postoperative Pain | Anesthesia, Local | Postoperative Cognitive Dysfunction | Scoliosis | Coagulation Disorder | Acute Pain | Neuropathic Pain | Anesthesia | Postoperative Nausea and Vomiting | Ventilator-Induced Lung Injury | Intraoperative Complications | Hyperalgesia | Regional... and other conditionsUkraine
-
Sun Yat-sen UniversityAkeso Pharmaceuticals, Inc.RecruitingNasopharyngeal Carcinoma | Nasopharyngeal CancerChina
-
Assaf-Harofeh Medical CenterCompletedPain | Prostate Cancer | Rectal/Anal
-
Boehringer IngelheimCompletedHepatitis CUnited States, Austria, Canada, France, Germany, Romania
-
Boehringer IngelheimTerminated
-
Boehringer IngelheimTerminated
-
InxMed (Shanghai) Co., Ltd.Recruiting
-
Boehringer IngelheimTerminated
-
MorphoSys AGClinigen Healthcare LtdApproved for marketing
-
Boehringer IngelheimCompletedDiabetes Mellitus, Type 2United States, Argentina, Hungary, India, Japan, Poland, Russian Federation
-
Boehringer IngelheimCompletedDiabetes Mellitus, Type 2United States, Australia, Hong Kong, Israel, New Zealand, Ukraine
-
National Cancer Institute (NCI)CompletedRecurrent Renal Cell Carcinoma | Stage IV Renal Cell CancerUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)CompletedRefractory Hodgkin Lymphoma | Refractory B-Cell Non-Hodgkin Lymphoma | Refractory T-Cell Non-Hodgkin Lymphoma | Hematopoietic Cell Transplantation RecipientUnited States
-
City of Hope Medical CenterNational Cancer Institute (NCI)Active, not recruitingRecurrent Mantle Cell Lymphoma | Recurrent Diffuse Large B-Cell Lymphoma | Refractory Diffuse Large B-Cell Lymphoma | Refractory Mantle Cell Lymphoma | Transformed Follicular Lymphoma to Diffuse Large B-Cell LymphomaUnited States
-
Northwestern UniversityBristol-Myers Squibb; National Cancer Institute (NCI); AbbVieWithdrawnRichter Syndrome | Transformed Chronic Lymphocytic Leukemia to Diffuse Large B-Cell Lymphoma | Transformed Small Lymphocytic Lymphoma to Diffuse Large B-Cell Lymphoma | Recurrent Transformed Chronic Lymphocytic Leukemia | Refractory Transformed Chronic Lymphocytic LeukemiaUnited States
-
Academic and Community Cancer Research UnitedNational Cancer Institute (NCI)Active, not recruitingRefractory B-Cell Non-Hodgkin Lymphoma | Recurrent B-Cell Non-Hodgkin Lymphoma | Recurrent Diffuse Large B-Cell Lymphoma | Recurrent Primary Mediastinal (Thymic) Large B-Cell Lymphoma | Refractory Diffuse Large B-Cell Lymphoma | Refractory Primary Mediastinal (Thymic) Large B-Cell Lymphoma | Recurrent... and other conditionsUnited States